DMI-9523 is nuclear factor NF-κB activation inhibitor. Antigen-stimulated human T lymphocytes produce significantly lower quantities of interferon-gamma and tumor necrosis factor-alpha after stimulation in vitro in the presence of DA-DKP. DA-DKP can modulate the inflammatory immune response through a molecular pathway implicated in T- lymphocyte anergy.

397847-46-0

C7H10N2O4

186.17

DMI 9523;DM-9523;Ampion;DA-DKP;DMI-9523

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years